Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

31.0K
Overview
31.0K
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

12.4K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
12.4K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

460
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
460

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revised Adaptive Immune Receptor Data in the Immune Epitope Database.

bioRxiv : the preprint server for biology·2026
Same author

Cancer epitope prediction tools and analysis pipelines in CEDAR.

Nucleic acids research·2026
Same author

VO: The Vaccine Ontology.

Scientific data·2026
Same author

The Cell Ontology in the age of single-cell omics.

Scientific data·2026
Same author

Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.

Nature microbiology·2026
Same author

NetMHCIIphosPan: a machine learning tool for predicting HLA class II antigen presentation of phosphorylated peptides.

bioRxiv : the preprint server for biology·2026
Same journal

VeloRM: disentangling pre- and post-splicing RNA modification dynamics at single-cell resolution.

Nucleic acids research·2026
Same journal

Accessibility of telomeric overhangs to stabilizing small-molecule ligands.

Nucleic acids research·2026
Same journal

Multivalent interactions mediate SNAIL transcription factor stimulation of the nucleosome deacetylase activity of the CoREST complex.

Nucleic acids research·2026
Same journal

Genome-wide mapping of DNA G-quadruplexes in Trypanosoma brucei chromatin reveals enrichment in coding regions and transcription start sites.

Nucleic acids research·2026
Same journal

Epigenetic landscape of synthetic human centromere core regions: CENP-A assembly and euchromatic modifications interdependently antagonize heterochromatin accumulation.

Nucleic acids research·2026
Same journal

MAPK/ERK signaling regulates H3K9me3 heterochromatin reorganization to confer mesendoderm developmental competence.

Nucleic acids research·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

14.9K

The Immune Epitope Database (IEDB): 2024 update.

Randi Vita1, Nina Blazeska1, Daniel Marrama1

  • 1Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

Nucleic Acids Research
|November 18, 2024
PubMed
Summary
This summary is machine-generated.

The Immune Epitope Database (IEDB) is a leading resource for immune epitope data, now enhanced with improved search, data exports, and quality. It supports research across various diseases and aims for broader data standardization.

More Related Videos

Zika Virus Specific Diagnostic Epitope Discovery
11:37

Zika Virus Specific Diagnostic Epitope Discovery

Published on: December 12, 2017

7.7K
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

12.3K

Related Experiment Videos

Last Updated: Jun 7, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

14.9K
Zika Virus Specific Diagnostic Epitope Discovery
11:37

Zika Virus Specific Diagnostic Epitope Discovery

Published on: December 12, 2017

7.7K
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

12.3K

Area of Science:

  • Immunology
  • Bioinformatics
  • Data Science

Background:

  • The Immune Epitope Database (IEDB) has served as a primary resource for immune epitope data for two decades.
  • It curates experimental data on epitopes related to infectious, allergic, autoimmune, and transplant diseases from scientific literature.

Purpose of the Study:

  • To detail recent enhancements to the IEDB, focusing on user-driven improvements and expanded capabilities.
  • To highlight the ongoing commitment to data quality and interoperability within the immunological research community.

Main Methods:

  • Manual curation of published epitope data from scientific literature.
  • Development and implementation of user-directed updates to the IEDB search interface.
  • Enhancement of advanced data export functionalities.
  • Improvement of data quality and standardization protocols.

Main Results:

  • Significant updates to the search interface, improving user experience and data accessibility.
  • Introduction of advanced data export options for researchers.
  • Demonstrated increases in data quality and consistency.
  • Strengthened interoperability with related scientific resources.

Conclusions:

  • The IEDB continues to evolve as a crucial, freely accessible public resource for immune epitope information.
  • Ongoing enhancements ensure the IEDB meets the needs of the research community and contributes to data standardization in immunology.
  • The resource is well-positioned for future contributions to immunological research and data management.